Metsera (MTSR) Soars to All-Time High on Pfizer, Novo Billion-Dollar Bidding War

We recently published 10 Stocks with Outstanding Gains; 9 on Record Highs. Metsera Inc. (NASDAQ:MTSR) is one of the best-performing stocks on Thursday.

Metsera rallied to a fresh all-time high on Thursday, as investor optimism was bolstered by a billion-dollar bidding war between pharmaceutical giants Pfizer Inc. and Novo Nordisk.

In intra-day trading, Metsera Inc. (NASDAQ:MTSR) jumped to a new 52-week high of $66.10 before trimming gains to end the day just up by 22.06 percent at $63.73 apiece.

This followed confirmation from Novo Nordisk that it submitted an $8.5 billion offer to acquire Metsera Inc. (NASDAQ:MTSR), 16 percent higher than Pfizer’s $7.3 billion offer, despite the latter already securing Metsera’s approval for the merger last month.

Meanwhile, Pfizer said that it was preparing to sue Metsera Inc. (NASDAQ:MTSR) and Novo Nordisk for breaching the agreement.

“It is an attempt by a company with a dominant market position to suppress competition in violation of law by taking over an emerging American challenger. It is also structured in a way to circumvent antitrust laws and carries substantial regulatory and executional risk,” Pfizer said.

“The proposal is illusory and cannot qualify as a superior proposal under Pfizer’s agreement with Metsera, and Pfizer is prepared to pursue all legal avenues to enforce its rights under its agreement,” it noted.

It can be learned that Pfizer earlier this year discontinued the clinical trial for its potential weight loss treatment, danuglipron, due to a case of potential drug-induced liver failure.

Metsera (MTSR) Soars to All-Time High on Pfizer, Novo Billion-Dollar Bidding War

Pixabay/Public domain

Last month, it announced plans to acquire Metsera, a clinical-stage biopharmaceutical company accelerating the next generation of medicines for obesity and cardiometabolic diseases, as it races to establish a foothold in the booming weight-loss drug market.

While we acknowledge the risk and potential of MTSR as an investment, our conviction lies in the belief that some AI stocks hold greater promise for delivering higher returns and doing so within a shorter time frame. If you are looking for an AI stock that is more promising than MTSR and that has 10,000% upside potential, check out our report about this cheapest AI stock.

READ NEXT: 30 Stocks That Should Double in 3 Years and 11 Hidden AI Stocks to Buy Right Now.

Disclosure: None. This article is originally published at Insider Monkey.